U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924229) titled 'Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment' on March 17.
Brief Summary: Aromatase inhibitors (AI) therapy is the treatment of choice for estrogen receptor-positive breast cancer (BC). While AIs effectively suppress tumor growth, estrogen deprivation may have negative impacts on the eyes. This work evaluated the anterior segment changes in estrogen-dependent BC after hormonal treatment.
Study Start Date: June 01, 2024
Study Type: INTERVENTIONAL
Condition:
Braest Cancer
Dry Eye
Intervention:
DRUG: Hormonal treatment
hormonal treatment for breast cancer
Recruitment Status: COMPLETED
Sponsor: ...